Monthly Archives: June 2016

Bioinformatics Market Size, Application Analysis, Regional Outlook, Competitive Strategies and Forecasts 2014 to 2020 | Hexa Research

“global bioinformatics market” is segmented on the basis of sectors, products & services and application. The implementation of information technology to manage biological information efficiently is known as bioinformatics.

Bioinformatics Market Size, Application Analysis, Regional Outlook, Competitive Strategies and Forecasts 2014 to 2020 | Hexa Research

Felton, United States – June 29, 2016 /MarketersMedia/

The rising incidences of chronic diseases globally coupled with the increasing demand of advanced drugs for the diagnosis of these diseases are expected to propel the growth for bioinformatics market.The implementation of information technology to manage biological information efficiently is known as bioinformatics. Decreasing cost of DNA sequencing, continuous advancement in information technology support for bioinformatics devices and increasing aids from government & private sector organizations for bioinformatics are some of the key factors which are triggering the growth of bioinformatics market over the forecast period. Apart from these, the factors like increasing initiatives by research institutions for discovery of novel drugs in life science and significant growth in usage of bioinformatics in the field of clinical diagnostics are few supporting drivers of this market.

Bioinformatics include genome annotation, gene sequence analysis, cancer mutation analysis, gene expression analysis, gene regulation analysis, protein expression analysis, comparative genomics and system biology. Continuous up-gradation in technology like cloud computing and nanopore technology has created a huge platform for storing, retrieving, analyzing, manipulating and organizing biological information. Adoption of computer technology for managing biological information also helps in developing drug and manage huge database associated which its discovery.

Access Detail Report with TOC @
http://www.hexaresearch.com/research-report/bioinformatics-industry/

Sectors Insights

The global bioinformatics market is segmented on the basis of sectors, products & services and application. On the basis of sector, market is further classified into medical biotechnology, animal biotechnology, academics, agriculture biotechnology, forensic biotechnology, environment biotechnology and others. Medical biotechnology is further divided into drug development, molecular medicines, clinical diagnostics, gene therapy and reproductive biotechnology. Forensic biotechnology is the fastest growing segment owing to increasing demand for DNA as evidence in our legal system. Medical biotechnology is contributing highest share in the entire bioinformatics sector market due to involvement of huge sunk cost.

Products and Services Insights

On the basis of products and services, bioinformatics market is divided into bioinformatics knowledge management tools, bioinformatics platform and bioinformatics services. Bioinformatics tool is bifurcated into specialized knowledge management tools and generalized knowledge management tools. Bioinformatics platforms is further classified into sequence analysis platforms, sequence manipulation platforms, sequence alignment platforms, structural & functional analysis platform, whereas bioinformatics services is classified into sequencing service, data analysis, database management and other services. Among all the mentioned sub segments, database management and data analysis is the critical and expensive part owing to involvement of technology for organizing data and humans for interpretation.

Request a Sample copy of “Bioinformatics Market” Report @
http://www.hexaresearch.com/sample/158

Application Insights

On the basis of application, market is segmented into genomics, proteomics, chemo informatics & drug design, transcriptomics, metabolomics, molecular phylogenetic and others. Genomics is expected to be the largest market segment by 2020 owing to its ability to understand even the most complex biological system like brain, whereas metabolomics is anticipated to be the fastest growing segment over the forecast period in order to decrease risk factors and identify biomarkers which helps to reveal embryo during pregnancy.

Regional Insights

Geographically, North America was the most dominant region in entire bioinformatics market, in 2014. Due to increasing adoption of latest technology, and continuous discovery & development of drugs, this market is expected to maintain its lead by 2020. Asia Pacific region is anticipated to show highest growth during the forecast period owing to the rapid increase in CRO activities, huge investment for introduction of IT in healthcare, growing medical tourism and growing academic and industry partnership. Countries like India, China and Brazil is expected to provide significant growth opportunities owing to increasing research outsourcing by pharmaceutical giants of developed nations.

Browse “Healthcare IT” Related Reports @
http://www.hexaresearch.com/research-category/healthcare-it-industry/

Competitive Insights

Some of the key market players of bioinformatics market are Affymetrix, Inc., Biomax Informatics AG, Agilent Technologies, Inc., CLC Bio, Illumina, Inc., Integromics S.L., Geneva Bioinformatics S.A., Id Business Solutions, Life Technology Corporation, ABM, Nonlinear Dynamics Ltd., Qiagen, Perkin Elmer and Dnanexus. Since the market is highly competitive, monopolistic and consolidated. Firms are adopting many strategies for the development of their business and creating differences with other firms who are serving the same market.

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexaresearch.com/research-report/bioinformatics-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/bioinformatics-market-size-application-analysis-regional-outlook-competitive-strategies-and-forecasts-2014-to-2020-hexa-research/121641

Release ID: 121641

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neovasc, Inc. – NVCN

NEW YORK, NY / ACCESSWIRE / June 29, 2016 / Pomerantz LLP is investigating claims on behalf of investors of Neovasc, Inc. (“Neovasc” or the Company) (NASDAQ: NVCN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

[Click here to join a class action]

The investigation concerns whether Neovasc and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On May 19, 2016, news outlets reported that a Massachusetts federal jury had awarded a $70 million verdict to Neovasc’s rival, CardiAQ Valve Technologies Inc. (“CardiAQ”), finding that Neovasc had stolen trade secrets from CardiAQ.

On this news, Neovasc’s share price fell $1.38, or 75%, to close at $0.46 on May 20, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 441824

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Deutsche Bank AG And Advises Investors With Losses To Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / June 29, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Deutsche Bank AG (“Deutsche Bank” or the “Company”) (NYSE: DB) concerning possible violations of federal securities laws between April 15, 2013 and April 29, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016, lead plaintiff motion deadline.

For more information or to participate, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, the Company failed to disclose that (1) Deutsche Bank has serious and systemic failings in its controls against financing terrorism, money laundering, aiding against international sanctions, and committing financial crimes; and (2) Deutsche Bank’s internal control over financial reporting and its disclosure controls and procedures were not effective.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 441823

Breast Pumps Market Share, Size, Trends, Analysis, Global Insights and Forecast up to 2020 Research by Hexa Research

Market research report on “Breast Pumps market” by Hexa Research provides a clear picture about the worldwide development of the Breast Pumps industry and recent key trends based on detailed statistical analysis.

Breast Pumps Market Share, Size, Trends, Analysis, Global Insights and Forecast up to 2020 Research by Hexa Research

Felton, United States – June 29, 2016 /MarketersMedia/

Market research report on Breast Pumps market by Hexa Research provides a clear picture about the worldwide development of the Breast Pumps industry and recent key trends based on detailed statistical analysis. This new report provides latest market data, including market estimate and forecast by application and product on a regional basis for historic years of 2012 and 2013 with forecast up to 2020.

This report is an invaluable resource for industry executives looking for key market data in readily available and clearly presented graphs and tables. Major regional markets covered in this report include North America, Europe, Asia Pacific and Rest of the world.

Browse Detail Report with TOC @
http://www.hexaresearch.com/research-report/breast-pumps-industry/

Additionally, the Breast Pumps market report includes comprehensive industry landscape, with market dynamics, drivers, restraints, opportunities and critical success factors. The Breast Pumps market report analyzes major companies dealing in this market and provides company market share analysis. The report also contains detailed profiles of key market players with product benchmarking and company revenue analysis.

The report firstly provides market segmentation, current market scenario, growth prospects and value chain analysis. Then the report deeply analyzes the Breast Pumps market conditions that include growth feasibility analysis, Porter’s five force analysis, PESTEL Analysis and market driver impact analysis. The growth feasibility analysis points out key areas in this market that deserve the most attention from market participants.

Overall, it is a comprehensive research report on the Global Breast Pumps market; Hexa research is thankful to industry experts related to Breast Pumps market for their valuable feedback and opinion during research compilation process.

Browse “Medical Devices” Related Reports:

Tumor Ablation Market
http://www.hexaresearch.com/research-report/tumor-ablation-market/

Gynecological Devices Market
http://www.hexaresearch.com/research-report/gynecological-device-market/

Reasons to Buy This Report

Find out global Breast Pumps Market size, growth rate and forecast to 2020
Key drivers and restraints of global Breast Pumps Market
Key opportunities in the Breast Pumps Market
Detailed regional estimates and forecast by application (North America, Europe, Asia Pacific, and Row) of global Breast Pumps Market
Competitive landscape, with Breast Pumps Market company market share and detailed profiles of key market players

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexaresearch.com/research-report/breast-pumps-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/breast-pumps-market-share-size-trends-analysis-global-insights-and-forecast-up-to-2020-research-by-hexa-research/121639

Release ID: 121639

DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Neovasc Inc. and Reminds Investors With Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 29, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) concerning possible violations of federal securities laws between January 26, 2015 and May 19, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 5, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, Neovasc made false and/or misleading statements and/or failed to disclose: that the Company’s Tiara device was developed through unlawful business practices such as misappropriation of trade secrets; that a related lawsuit against Neovasc regarding the misappropriation of trade secrets had merit; and that as a result the Company’s statements about business, operations, and prospects were materially false and misleading.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 441818

Electric Vehicles (EV) Market is Likely to Experience High Growth in Automotive Industry Research by Hexa Reports

North America is likely to witness major market share due to its growth in vehicle market, rigorous norms for emissions, and government subsidize provided for “electric vehicles”.

Electric Vehicles (EV) Market is Likely to Experience High Growth in Automotive Industry Research by Hexa Reports

Felton, United States – June 29, 2016 /MarketersMedia/

With increase in demand of enhanced fuel economy and rising fuel prices in vehicle are anticipated to drive vehicle electrification Industry growth globally. Stringent government policies on harmful emissions from Carbon dioxide and rise in pollution are driving the electrification industry from past few years. This market is likely to experience high growth due to rising requirement for electric systems in tax exemptions, vehicles and subsidies by the government with increase in diesel and petrol prices. Major Products in Electric vehicles market are Electric power steering, electric water pump, thermoelectric generator, electric oil pump, electric vacuum pump, electric mobile phone charger and liquid heater PTC.

Key players for Electric Vehicles market are JTEKT Corporation, Visteon Corporation, NSK ltd, Denso Corporation, Friedrichshafen AG, BorgWarner Inc and Nexteer Automotive Group Ltd

Browse Detail Report with TOC @
http://www.hexareports.com/report/electric-vehicles-ev-market/details

Largest Electric Power steering is expected to contribute for the major market share due to potential of ensuring the safe and secure driving in vehicles from hydraulic power steering. This segment is further estimated to provide low energy consumption ,better handling and reduced weight in vehicles which ultimately gives a strong place to market of Electric Power Systems. North America is likely to witness major market share due to its growth in vehicle market, rigorous norms for emissions, and government subsidize provided for electric vehicles.

Classification of Electric Vehicle Industry can be done on degree of hybridization into Internal Combustion Engine & micro hybrid vehicle, Battery electric vehicle, Fuel cell electric vehicle, plug in hybrid electric vehicle and hybrid Electric vehicle. Asia Pacific is expected to hold the significant growth with rising expansion of automotive industry in the area. Increasing number of vehicles manufactured companies owing to its cheap cost production facilities may propel industry growth in upcoming years. Hybrid Electric vehicle is likely to experience significant growth owing to its capability in combining two dissimilar power sources like petrol/diesel and electric power.

Request a Sample copy of “Electric Vehicles (EV) Market” Report @
http://www.hexareports.com/sample/46060

For More Reports on “Automotive” Visit @
http://www.hexareports.com/category/automotive-market

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe.We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexareports.com/report/electric-vehicles-ev-market/details

Contact Info:
Name: Ryan Shaw
Organization: Hexa Reports
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/electric-vehicles-ev-market-is-likely-to-experience-high-growth-in-automotive-industry-research-by-hexa-reports/121637

Release ID: 121637

Axial Spondyloarthritis Pipeline Market 2016 Global Review

RnRMarketResearch.com adds Axial Spondyloarthritis Pipeline Market Research to its database.

Axial Spondyloarthritis Pipeline Market 2016 Global Review

Pune, India – June 29, 2016 /MarketersMedia/

Axial Spondyloarthritis Pipeline Market Companies Involved in Therapeutics Development are AbbVie Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Sandoz International GmbH, UCB S.A. and Xbrane Biopharma AB.

The report provides comprehensive information on the therapeutics under development for Axial Spondyloarthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Axial Spondyloarthritis and features dormant and discontinued projects.

Inquire more about this research report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=621850

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

– The report provides a snapshot of the global therapeutic landscape of Axial Spondyloarthritis

– The report reviews pipeline therapeutics for Axial Spondyloarthritis by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Axial Spondyloarthritis therapeutics and enlists all their major and minor projects

– The report assesses Axial Spondyloarthritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Axial Spondyloarthritis

Complete research report of 108 pages with TOC is available at http://www.rnrmarketresearch.com/axial-spondyloarthritis-pipeline-review-h1-2016-market-report.html

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Axial Spondyloarthritis

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Axial Spondyloarthritis pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/axial-spondyloarthritis-pipeline-market-2016-global-review/121615

Release ID: 121615

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Chiasma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 – CHMA

NEW YORK, NY / ACCESSWIRE / June 29, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Chiasma, Inc. (“Chiasma”) (NASDAQ: CHMA) between July 15, 2015 and April 17, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Massachusetts. To get more information go to:

http://www.zlk.com/pslra/chiasma

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, among other allegations, defendants made false and/or misleading statements and/or failed to disclose that (i) Chiasma’s Phase 3 clinical trial methodology for Mycapssa was not sufficient to demonstrate efficacy and secure approval by the U.S. Food and Drug Administration (“FDA”); (ii) Chiasma’s supervision of its suppliers was not sufficient to prevent deficiencies that would delay FDA approval of Mycapssa; and (iii) as a result of the foregoing, Chiasma’s public statements were materially false and misleading at all relevant times.

On April 15, 2016, the Company announced the receipt of a Complete Response Letter from the FDA, indicating that Chiasma’s New Drug Application for Mycapssa was not yet ready for approval. Following a review of the Letter, the Company issued a release on April 18, 2016, clarifying the FDA’s concerns, noting that the FDA recommended Chiasma “conduct a randomized, double-blind and controlled trial…of sufficiently long duration…”

If you suffered a loss in Chiasma you have until August 8, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 441819

ICE and Catch Star Studios Create Original Broadcast and Interactive Digital Programming – “Stars and PinStripes” airing on the YES Network

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / June 29, 2016 / INTELLIGENT CONTENT ENTERPRISES INC. (OTCQB: ICEIF) (“ICE” or the “Corporation”), is pleased to announce that in conjunction with its wholly owned subsidiary, ICE Studio Productions Inc., (“ICE Productions”) it has signed an agreement with the YES Network to air Catch Star Studios LLC’s (“Catch Star Studios”) original programming series, Stars and PinStripes, beginning in August.

This new and original series on YES features an elite cast of some of today’s iconic and inspirational celebrities from all walks of life sharing their personal New York Yankees and life experiences and will showcase their current projects and initiatives. An original 30-minute episode will premiere each month on YES beginning in August.

Hosted by Nancy Newman, award winning YES Network studio host and also the host of the network’s Yankees Magazine show, Stars and PinStripes will be available to approximately 12 million households on the YES Network nationwide as well as globally via online and mobile devices through ICE’s Digital Widget Factory platform at www.digiwidgy.com. Show segments will also be available on www.YESNetwork.com.

Segments of Stars and PinStripes episodes will also be available through www.digiwidgy.com as online and mobile webisodes enhanced with closed caption language-translation technology available in over 50 different global languages, seamlessly translated to the appropriate language for each geographic viewing experience.

Both Ice Productions and Catch Star Studios will receive production credit for the Stars and PinStripes original series. On May 25, 2016, ICE www.intelligentcontententerprises.com announced that the Corporation has signed an initial agreement to license to acquire all the technology, production and client operations owned and operated by New York based Catch Star Studios LLC www.catchstarstudios.com. The integration of ICE’s digiwidy.com proprietary platform with Catch Star Studios’ original content, Stars and PinStripes demonstrates the synergy of ICE’s trending model to drive revenue through technologies, platforms and services that deliver Content, Social and Digital Media, eCommerce and Advertising.

To enhance the value of revenue generation opportunities in addition to the broadcast commercials and potential sponsorship, Stars and PinStripes’ digital broadcast will feature Clix.Video™ an application designed by Catch Star Studios’ interactive video technology team. Clix.Video™ enables digital and mobile viewers to instantaneously connect to web and mobile sites by clicking on custom interactive tags within the video broadcasts to make social media connections, to review extra and exclusive content and make online and mobile purchases directly via the video broadcast providing a richer, deeper consumer experience related to the video content.

Catch Star Studios is currently reviewing additional sports and celebrity original programming opportunities to provide rich, broadcast and digital strategies that support interactive video and multi-lingual global user engagement.

About Catch Star Studios, LLC

Catch Star Studios provides development services, management and technologies that creates new and enables existing sport and other branded content to be consumed globally through traditional and online media channels. Catch Star Studios also develops and executes world class engagement initiatives enabling brands to extend global video content, reach advertising and direct revenue opportunities through Catch Star Studios’ proprietary “in video” marketing platform.

For more information, please visit www.catchstarstudios.com

About Intelligent Content Enterprises Inc.

Intelligent Content Enterprises Inc. (ICE) is an emerging Media and Internet company that focuses on the experience of the user, creating brands, products and destinations globally, regionally and by language that are value driven proving an informative, entertaining and engaging look at content.

ICE’s 4 pillar strategy is to drive revenue through technologies, platforms and services that deliver Content, Social and Digital Media, eCommerce and Advertising.

ICE’s first acquisition, Digital Widget Factory provides the baseline infrastructure and technology platform enabling of content and media to be disseminated globally, efficiently and effectively, creating economies of scale for distribution in over 50 languages, allowing users to create and participate in the content process and consumption.

Intelligent Content Enterprises is a publicly traded company on the OTCQB Markets under the symbol “ICEIF”

For further information, please contact:

Investor Relations: investorrelations@intelligentcontententerprises.com

FORWARD LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, ICE assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although ICE believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because ICE can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in ICE’s disclosure documents which can be found under ICE’s profile on www.sedar.com.

This press release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company’s Form 6-K and 20F filings with the Securities and Exchange Commission.

SOURCE: Intelligent Content Enterprises Inc.

ReleaseID: 441817

Investor Calendar Invites You to the Lindsay Corporation Third Quarter 2016 Earnings Webcast Live on Thursday, June 30, 2016

OMAHA, NB / ACCESSWIRE / June 29, 2016 / Lindsay Corporation (NYSE: LNN) will host a live webcast to discuss the results of the third quarter 2016, to be held Thursday, June 30, 2016 at 11:00 AM Eastern Time.

To participate in this event, listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=175078 as well as via the Lindsay Corporation website (www.lindsay.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.lindsay.com.

About Lindsay Corporation

Lindsay manufactures and markets water management equipment and services including irrigation systems, pump stations, filtration, and M2M controls designed to increase or stabilize crop production while conserving water, energy, and labor, and that also provide efficiency benefits in various industrial applications. The Company also manufactures and markets infrastructure and road safety products under the Lindsay Transportation Solutions trade name. Lindsay’s shares are traded on the New York Stock Exchange under the symbol LNN. For more information regarding Lindsay Corporation, see Lindsay’s website at www.lindsay.com.

SOURCE: Investor Calendar

ReleaseID: 441460